<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Neurol</journal-id><journal-id journal-id-type="iso-abbrev">Front Neurol</journal-id><journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id><journal-title-group><journal-title>Frontiers in Neurology</journal-title></journal-title-group><issn pub-type="epub">1664-2295</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38125835</article-id><article-id pub-id-type="pmc">PMC10732506</article-id><article-id pub-id-type="doi">10.3389/fneur.2023.1323626</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neurology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Combination of intraoperative indocyanine green video-angiography FLOW 800 and computed tomography perfusion to assess the risk of cerebral hyperperfusion syndrome in chronic internal carotid artery occlusion patients after revascularization surgery</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Du</surname><given-names>Juan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn0001" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Shen</surname><given-names>Jun</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="fn0001" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Jian</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1246292/overview"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Fayong</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Mao</surname><given-names>Renling</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Xu</surname><given-names>Yinghua</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><xref rid="fn0002" ref-type="author-notes">
<sup>&#x02021;</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Duan</surname><given-names>Yu</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><xref rid="fn0002" ref-type="author-notes">
<sup>&#x02021;</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1047100/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Neurology, Huadong Hospital, Fudan University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Neurology, Shanghai East Hospital, Tongji University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Neurosurgery, Huadong Hospital, Fudan University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff><aff id="aff4"><sup>4</sup><institution>Department of Neurosurgery, Huashan Hospital, Fudan University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff><aff id="aff5"><sup>5</sup><institution>Departments of Anesthesiology, Huadong Hospital, Fudan University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by" id="fn0003"><p>Edited by: Fernando Delgado, Andusian Health Service, Spain</p></fn><fn fn-type="edited-by" id="fn0004"><p>Reviewed by: Carlos P&#x000e9;rez-Garc&#x000ed;a, San Carlos University Clinical Hospital, Spain; Tomohiro Inoue, NTT Medical Center, Japan</p></fn><corresp id="c001">*Correspondence: Yinghua Xu, <email>13641821820@139.com</email>; Yu Duan, <email>duanyu926@163.com</email></corresp><fn fn-type="equal" id="fn0001"><p><sup>&#x02020;</sup>These authors share first authorship</p></fn><fn fn-type="equal" id="fn0002"><p><sup>&#x02021;</sup>These authors have contributed equally to this work</p></fn></author-notes><pub-date pub-type="epub"><day>05</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>14</volume><elocation-id>1323626</elocation-id><history><date date-type="received"><day>18</day><month>10</month><year>2023</year></date><date date-type="accepted"><day>17</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2023 Du, Shen, Li, Zhang, Mao, Xu and Duan.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Du, Shen, Li, Zhang, Mao, Xu and Duan</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><sec id="sec1"><title>Background and purpose</title><p>To study the changes of corticocerebral hemodynamics in surgical area and postoperative hyperperfusion syndrome in patients with chronic internal carotid artery occlusion (CICAO) by intraoperative indocyanine green videoangiography (ICGA)-FLOW 800 and CT perfusion after superficial temporal artery (STA)&#x02013;middle cerebral artery (MCA) bypass surgery.</p></sec><sec id="sec2"><title>Methods</title><p>From October 2019 to January 2021, 77 patients diagnosed with CICAO underwent direct bypass surgery at Huadong hospital (affiliated with Fudan University) were enrolled. Regions of interest (ROIs) at STA, proximal MCA (PMCA), distal MCA (DMCA), cortical blood capillary (CBC), and cortical vein (CV) were identified after anastomosis by ICGV-FLOW 800 including peak fluorescence intensity (PFI), time to peak (TTP), and area under the time curve (AUC) of fluorescence intensity. All patients underwent perfusion-weighted CT before bypass surgery and those patients with HPS were verified by CTP after bypass.</p></sec><sec id="sec3"><title>Results</title><p>14 patients with HPS were verified by perfusion-weighted CT after bypass. In HPS group, the AUC<sub>TTP</sub> of DMCA was significantly larger (T&#x02009;=&#x02009;&#x02212;3.301, <italic>p</italic>&#x02009;=&#x02009;0.004) and TTP of CBC was shorter (T&#x02009;=&#x02009;&#x02212;2.929, <italic>p</italic>&#x02009;=&#x02009;0.005) than patients in non-HPS group. The larger AUC<sub>TTP</sub> of DMCA (OR&#x02009;=&#x02009;3.024, 95%CI 1.390&#x02013;6.578, <italic>p</italic>&#x02009;=&#x02009;0.0050) was an independent risk factor by further multivariate logistic regression analysis.</p></sec><sec id="sec4"><title>Conclusion</title><p>The hemodynamic changes of cortical vessels during STA-MCA bypass surgery could be recorded accurately by ICGV-FLOW 800. Furthermore, the increased AUC<sub>TTP</sub> of DMCA and shorter TTP of CBC may be potential risk factors of HPS.</p></sec></abstract><kwd-group><kwd>chronic internal carotid artery occlusion</kwd><kwd>fluorescein angiography</kwd><kwd>cerebral revascularization</kwd><kwd>regional cerebral blood flow</kwd><kwd>hyperperfusion syndrome</kwd></kwd-group><funding-group><award-group><funding-source id="cn1"><institution-wrap><institution>Natural Science Foundation of China</institution><institution-id institution-id-type="doi">10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id award-type="contract" rid="cn1">82071313</award-id></award-group><funding-statement>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Funding for this study was provided by Natural Science Foundation of China (No. 82071313), China.</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="1"/><equation-count count="0"/><ref-count count="37"/><page-count count="7"/><word-count count="4607"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Stroke</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec5"><title>Introduction</title><p>Chronic internal carotid artery occlusion (CICAO) is a rare cerebrovascular disease that is characterized by progressive stenosis to occlusion in internal carotid arteries (<xref rid="ref1" ref-type="bibr">1</xref>). The main treatment for CICAO is revascularization surgery, especially superficial temporal artery (STA)&#x02013;middle cerebral artery (MCA) bypass surgery, which can directly and efficiently establish sufficient blood flow from the extracranial artery to the intracranial artery to improve cerebral perfusion (<xref rid="ref2" ref-type="bibr">2</xref>). Hyperperfusion syndrome (HPS) is a common hemodynamics-related complication that may lead to neurological deficits, including cerebral hemorrhage or ischemia, after revascularization (<xref rid="ref3" ref-type="bibr">3</xref>, <xref rid="ref4" ref-type="bibr">4</xref>). However, at present, there are no reliable models and/or methods to predict the occurrence of HPS in patients with CICAO after STA-MCA bypass surgery.</p><p>Indocyanine green video-angiography (ICGA) FLOW 800 software (Carl Zeiss Meditec AG) can record time-delayed dynamic video and calculate the hemodynamic parameters of regions of interest (ROIs) at cortical surfaces. ICGA has been gradually introduced in bypass surgery for CICAO because of its high spatial resolution and excellent image quality with reliable real-time parametric variation in cortical vessel flow (<xref rid="ref5" ref-type="bibr">5</xref>).</p><p>In this retrospective cohort study, we investigate the mechanism of HPS in patients with CICAO after STA-MCA bypass surgery and further discuss the determinant by hemodynamic parameters changes in different blood flow periods collected by ICGA-FLOW 800 technology.</p></sec><sec sec-type="materials|methods" id="sec6"><title>Materials and methods</title><sec id="sec7"><title>Clinical data</title><p>From October 2019 to January 2021, patients diagnosed with CICAO were retrospectively enrolled at Huadong Hospital (affiliated with Fudan University). This study was approved by the Ethics Committee of Huadong Hospital (20190030). All patients signed informed consent forms.</p><p>Inclusion criteria: aged between 14 and 75&#x02009;years old; at II&#x02013;VI period by Suzuki stage with internal carotid artery occlusion or stenosis (<xref rid="ref6" ref-type="bibr">6</xref>); no prior intracranial and extracranial vascular anastomosis of any kind; received STA-MCA bypass surgery; after anastomosis, and cortex blood flow tested by ICGA. Exclusion criteria: patients with internal carotid artery or MCA occlusion caused by atherosclerosis without a preoperative and/or postoperative computerized tomography perfusion imaging (CTP) test.</p></sec><sec id="sec8"><title>STA-MCA bypass</title><p>To perform bypass surgery, the head of the patient was positioned at 60 degrees to the opposite side. The scalp was then incised, and the temporal muscle was isolated from the temporal lobe. After milling the skull, cutting the dura mater, and confirmation of a suitable receptor (MCA-M4 segment, diameter<inline-formula>
<mml:math id="M1" overflow="scroll"><mml:mo>&#x02265;</mml:mo></mml:math>
</inline-formula>0.8&#x02009;mm; <xref rid="fig1" ref-type="fig">Figure 1A</xref>), STA was towed through the temporal muscle. After anastomosis, 0.2&#x02009;mg/kg indocyanine green (Dandong Medical and Pharmaceutical Co., Ltd., China) with 10&#x02009;mL of normal saline was intravenously injected at a high rate of speed. The ROIs at the STA, the proximal part of MCA (PMCA), distal part of MCA (DMCA), cortical blood capillary (CBC), and the cortical vein (CV) around the anastomoses were selected using fluorescence angiography (OPMI Pentero fluorescence microscope, Carl Zeiss, Germany; <xref rid="fig1" ref-type="fig">Figure 1B</xref>). If the fluorescence intensity (PFI) of the blood vessel rises early, the vessel will appear darker red in the composite image, whereas if the PFI rises later, the vessel will appear dark blue (<xref rid="fig1" ref-type="fig">Figure 1C</xref>). The coordinate plot of the fluorescence intensity over time and its original data were automatically generated using FLOW-800 microscope (<xref rid="fig1" ref-type="fig">Figure 1D</xref>). Time to peak (TTP) indicates the time from the beginning of fluorescence to the strongest fluorescence. The area under the curve (AUC) from the origin of the coordinates to the TTP indicated as AUC<sub>TTP</sub>, was calculated using GraphPad Prism 8.0 (GraphPad Software, United States). The value of PFI, TTP, and AUC<sub>TTP</sub> were analyzed.</p><fig position="float" id="fig1"><label>Figure 1</label><caption><p>A 56-year-old female developed temporary motor aphasia and dysphagia at 3&#x02009;days after left STA-MCA direct bypass surgery. <bold>(A)</bold> Microscopic image during bypass surgery. STA was marked as &#x02460;, DMCA as &#x02461;, PMCA as &#x02462;, CBC as &#x02463; and &#x02464;, and CV as &#x02465;. <bold>(B)</bold> Intraoperative indocyanine green video-angiography image. <bold>(C)</bold> Schematic diagram of each peak blood flow time; the redder, the peak is the earlier, the bluer, the peak is the later; <bold>(D)</bold> Fluorescence intensity&#x02014;time curve at each interest vessels. The value of AUC<sub>TTP</sub> at STA (mark 1) and DMCA (mark 2) increased significantly. STA, Superficial temporal artery; DMCA, The distal part of middle cerebral artery; PMCA, The proximal part of middle cerebral artery; CBC, Cortical blood capillary; and CA, Cortical vein.</p></caption><graphic xlink:href="fneur-14-1323626-g001" position="float"/></fig></sec><sec id="sec9"><title>Perioperative management</title><p>Maintaining stable blood pressure and ensuring the balance of inflow and outflow, the adverse reactions were recorded in detail. These included the following: (1) persistent headache for more than 72&#x02009;h; (2) muscle weakness, seizures, and aphasia. Patients with adverse reactions were tested by CT or MRI immediately to exclude intracerebral hemorrhage or a fresh infarction.</p></sec><sec id="sec10"><title>Computerized tomography perfusion imaging acquisition and analysis</title><p>All patients underwent a CTP test (GE LightSpeed VCT 64 Slice CT Scanner) to determine cerebral perfusion status and not all patients were reviewed for CTP after surgery because of radiation hazards. However, once adverse reaction occurred in patients similar to HPS postoperatively, we would actively review CTP test to determine whether HPS was present. A head retainer was used to keep the patient&#x02019;s head as stationary as possible during the scan. Ioformol (Hengrui Co. Ltd., China) was administered via the median cubital vein at a flow rate of 5.0&#x02009;mL/s at a dose of 50&#x02009;mL. The scan parameters were as follows: tube voltage&#x02009;=&#x02009;80&#x02009;kV, tube current&#x02009;=&#x02009;120&#x02013;150&#x02009;mA, layer thickness&#x02009;=&#x02009;1.25&#x02009;mm, total scanning time&#x02009;=&#x02009;60&#x02009;s; the plateau, inflow, and outflow period were all included. Data were automatically analyzed using brain perfusion CT image processing software (PerfusionGo V1.0; Shukun, Co. Ltd., China) via a singular value decomposition and deconvolution algorithm for dispersion correction (<xref rid="fig2" ref-type="fig">Figure 2</xref>).</p><fig position="float" id="fig2"><label>Figure 2</label><caption><p>The patients were performed by CTP at the fourth day after bypass surgery. <bold>(A&#x02013;C)</bold> Digital subtraction angiography showed left initial internal carotid artery was occluded, right the left internal carotid artery and bilateral vertebral artery systems is normal, but without obvious compensation. <bold>(D)</bold> Postoperative CT angiography showed the blood flow at anastomosis was patent (red arrow). <bold>(E&#x02013;H)</bold>: Preoperative CTP showed the mismatch green area (Tmax&#x0003e;6&#x02009;s) was 93.1&#x02009;mL and the hypoperfusion red area (rCBF&#x0003c;30%) was 0.6&#x02009;mL at frontotemporal parietal lobe (black arrow). <bold>(I&#x02013;L)</bold> Postoperative CTP showed mismatch area reduced significantly and hypoperfusion area disappeared. <bold>(M&#x02013;P)</bold> Figures of CTP showed CBV, CBF, and MTT and Tmax, respectively, before bypass. The values of CBV and CBF were normal, the values of MTT and Tmax lengthened at left frontotemporal parietal lobe. <bold>(Q&#x02013;T)</bold> The values of CBV and CBF were still normal, and the values of MTT and Tmax shortened significantly after bypass surgery.</p></caption><graphic xlink:href="fneur-14-1323626-g002" position="float"/></fig></sec><sec id="sec11"><title>Identification of HPS</title><p>If patients show postoperative adverse reactions, CTP should be performed. According to a procedure described in a previous study (<xref rid="ref7" ref-type="bibr">7</xref>), HPS was confirmed by CTP after bypass as follows: (1) Mismatch area and/or hypoperfusion red area (rCBF&#x02009;&#x0003c;&#x02009;30%) reduce significantly; (2) CBV and CBF increased or MTT and TTP reduced significantly at the anastomotic region; and (3) Without fresh hemorrhage or infarction.</p></sec><sec id="sec12"><title>Statistical analysis</title><p>The SPSS v.23.0 statistical software package was used to process the data. Continuous variables were verified using the Kolmogorov&#x02013;Smirnov normality test. Normal distributional data were represented by mean&#x02009;&#x000b1;&#x02009;standard deviation (<inline-formula>
<mml:math id="M2" overflow="scroll"><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo stretchy="true">&#x000af;</mml:mo></mml:mover></mml:math>
</inline-formula>&#x000b1;<italic>s</italic>) and the differences between two groups were detected by an independent <italic>t</italic>-test. Nonnormal distributional data were compared using the Mann&#x02013;Whitney U test. Categorical variables were represented as frequencies and compared by the &#x003c7;<sup>2</sup> test. The risk factors for HPS were calculated using multivariate logistic regression. A <italic>p</italic> value of &#x0003c;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec13"><title>Results</title><sec id="sec14"><title>General information</title><p>A total of 77 patients were included in this study (37 males and 40 females), with an average age of 42.2&#x02009;&#x000b1;&#x02009;13.3&#x02009;years, ranging from 31 to 72&#x02009;years. According to the clinical classification criteria of Matsushima, 34 patients suffered from transient ischemic attack (TIA), 24 from cerebral infarction, and 19 from cerebral hemorrhage. According to Suzuki staging, 9 cases were at level II, 21 cases were at level III, 14 cases were at IV level, 19 cases were at level V, and 14 cases were at level VI.</p></sec><sec id="sec15"><title>Postoperative adverse reactions and HPS syndrome</title><p>23 patients had moderate to severe adverse reaction after bypass surgery, 20 received postoperative CTP test, and finally, 14 patients (18.2%) were confirmed to be in the HPS group. The main postoperative adverse events were swallowing dysfunction or salivation (five cases), persistent headache (five cases), epilepsy (two cases), and contralateral muscle strength weakness (two cases; <xref rid="tab1" ref-type="table">Table 1</xref>).</p><table-wrap position="float" id="tab1"><label>Table 1</label><caption><p>Comparison of clinical data between HPS group and non-HPS group of patients with chronic internal carotid artery occlusion.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="2" colspan="1">Relevant parameters</th><th align="center" valign="top" colspan="4" rowspan="1">Univariate analysis</th><th align="center" valign="top" colspan="2" rowspan="1">Multiple regression analysis</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">HPS group (<italic>n</italic>&#x02009;=&#x02009;14)</th><th align="center" valign="top" rowspan="1" colspan="1">Non-HPS group (<italic>n</italic>&#x02009;=&#x02009;63)</th><th align="center" valign="top" rowspan="1" colspan="1">Test value</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic> value</th><th align="center" valign="top" rowspan="1" colspan="1">OR (95%, confidence intervals)</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic> value</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Clinical features</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Male (<italic>n</italic>, %)</td><td align="center" valign="middle" rowspan="1" colspan="1">6(42.9%)</td><td align="center" valign="middle" rowspan="1" colspan="1">31(49.2%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.185<sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.667</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age (years old,&#x02009;&#x000b1;&#x02009;s)</td><td align="center" valign="middle" rowspan="1" colspan="1">50.4&#x02009;&#x000b1;&#x02009;13.3</td><td align="center" valign="middle" rowspan="1" colspan="1">40.3&#x02009;&#x000b1;&#x02009;13.5</td><td align="center" valign="middle" rowspan="1" colspan="1">-2.518<sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.014</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hypertension (<italic>n</italic>, %)</td><td align="center" valign="middle" rowspan="1" colspan="1">3(21.4%)</td><td align="center" valign="middle" rowspan="1" colspan="1">24(38.1%)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.397 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.085</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hyperlipidemia (<italic>n</italic>, %)</td><td align="center" valign="middle" rowspan="1" colspan="1">6(42.9%)</td><td align="center" valign="middle" rowspan="1" colspan="1">17(27.0%)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.378 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.241</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Diabetes (<italic>n</italic>, %)</td><td align="center" valign="middle" rowspan="1" colspan="1">4(28.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">20(31.7%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.054 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.817</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Surgery at dominant hemisphere (<italic>n</italic>, %)</td><td align="center" valign="middle" rowspan="1" colspan="1">11(78.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">3(21.4%)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.584 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.058</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Clinical classification</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.475 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.636</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TIA</td><td align="center" valign="middle" rowspan="1" colspan="1">7(50.0%)</td><td align="center" valign="middle" rowspan="1" colspan="1">27(42.9%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cerebral infarction</td><td align="center" valign="middle" rowspan="1" colspan="1">4(28.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">20(31.7%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cerebral hemorrhage</td><td align="center" valign="middle" rowspan="1" colspan="1">3(21.4%)</td><td align="center" valign="middle" rowspan="1" colspan="1">16(25.4%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Suzuki stage</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.339 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.735</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">II</td><td align="center" valign="middle" rowspan="1" colspan="1">1(7.1%)</td><td align="center" valign="middle" rowspan="1" colspan="1">8(12.7%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">III</td><td align="center" valign="middle" rowspan="1" colspan="1">4(28.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">17(27.0%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IV</td><td align="center" valign="middle" rowspan="1" colspan="1">2(14.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">12(19.0%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">V</td><td align="center" valign="middle" rowspan="1" colspan="1">5(35.7%)</td><td align="center" valign="middle" rowspan="1" colspan="1">14(22.2%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">VI</td><td align="center" valign="middle" rowspan="1" colspan="1">2(14.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">12(19.0%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Systolic blood pressure</td><td align="center" valign="middle" rowspan="1" colspan="1">108.0&#x02009;&#x000b1;&#x02009;6.3</td><td align="center" valign="middle" rowspan="1" colspan="1">109.3&#x02009;&#x000b1;&#x02009;5.0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.792 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.431</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Diastolic blood pressure</td><td align="center" valign="middle" rowspan="1" colspan="1">80.4&#x02009;&#x000b1;&#x02009;6.5</td><td align="center" valign="middle" rowspan="1" colspan="1">78.9&#x02009;&#x000b1;&#x02009;5.6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.921<sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.3601</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">TTP</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">STA</td><td align="center" valign="middle" rowspan="1" colspan="1">25.45&#x02009;&#x000b1;&#x02009;5.02</td><td align="center" valign="middle" rowspan="1" colspan="1">27.64&#x02009;&#x000b1;&#x02009;4.58</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.678</td><td align="center" valign="top" rowspan="1" colspan="1">0.093</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PMCA</td><td align="center" valign="middle" rowspan="1" colspan="1">25.75(23.26,30.48)</td><td align="center" valign="middle" rowspan="1" colspan="1">27.76(25.37,31.09)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.110</td><td align="center" valign="top" rowspan="1" colspan="1">0.267</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DMCA</td><td align="center" valign="middle" rowspan="1" colspan="1">24.74(21.92,30.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">27.45&#x02009;&#x000b1;&#x02009;4.65</td><td align="center" valign="middle" rowspan="1" colspan="1">1.356</td><td align="center" valign="top" rowspan="1" colspan="1">0.557</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CBC</td><td align="center" valign="middle" rowspan="1" colspan="1">25.47(22.37,31.95)</td><td align="center" valign="middle" rowspan="1" colspan="1">29.16(26.23,31.31)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.168</td><td align="center" valign="top" rowspan="1" colspan="1">0.045</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.892,0.786&#x02009;~&#x02009;1.012</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.077</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CV</td><td align="center" valign="middle" rowspan="1" colspan="1">28.71(24.06,35.55)</td><td align="center" valign="middle" rowspan="1" colspan="1">31.73(28.56,34.39)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.162</td><td align="center" valign="top" rowspan="1" colspan="1">0.872</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">PFI</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">STA</td><td align="center" valign="middle" rowspan="1" colspan="1">1477.3&#x02009;&#x000b1;&#x02009;110.6</td><td align="center" valign="middle" rowspan="1" colspan="1">1503.5&#x02009;&#x000b1;&#x02009;79.0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.149</td><td align="center" valign="middle" rowspan="1" colspan="1">0.882</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PMCA</td><td align="center" valign="middle" rowspan="1" colspan="1">1807.4&#x02009;&#x000b1;&#x02009;160.3</td><td align="center" valign="middle" rowspan="1" colspan="1">1699.7&#x02009;&#x000b1;&#x02009;81.6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.57</td><td align="center" valign="middle" rowspan="1" colspan="1">0.57</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DMCA</td><td align="center" valign="middle" rowspan="1" colspan="1">2050.5&#x02009;&#x000b1;&#x02009;171.4</td><td align="center" valign="middle" rowspan="1" colspan="1">1901.0&#x02009;&#x000b1;&#x02009;111.4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.597</td><td align="center" valign="middle" rowspan="1" colspan="1">0.552</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CBC</td><td align="center" valign="middle" rowspan="1" colspan="1">1613.9&#x02009;&#x000b1;&#x02009;153.1</td><td align="center" valign="middle" rowspan="1" colspan="1">1467.6&#x02009;&#x000b1;&#x02009;85.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.75</td><td align="center" valign="middle" rowspan="1" colspan="1">0.455</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CV</td><td align="center" valign="middle" rowspan="1" colspan="1">1308.1&#x02009;&#x000b1;&#x02009;92.8</td><td align="center" valign="middle" rowspan="1" colspan="1">1135.7&#x02009;&#x000b1;&#x02009;55.9</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.361</td><td align="center" valign="middle" rowspan="1" colspan="1">0.178</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AUC</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">STA</td><td align="center" valign="middle" rowspan="1" colspan="1">1.91&#x02009;&#x000b1;&#x02009;0.79</td><td align="center" valign="middle" rowspan="1" colspan="1">1.61&#x02009;&#x000b1;&#x02009;0.69</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.929</td><td align="center" valign="top" rowspan="1" colspan="1">0.182</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PMCA</td><td align="center" valign="middle" rowspan="1" colspan="1">1.84(1.50,2.06)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.25(0.97,1.56)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.205</td><td align="center" valign="top" rowspan="1" colspan="1">0.968</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DMCA</td><td align="center" valign="middle" rowspan="1" colspan="1">2.31(2.01,3.55)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.84(1.44,2.37)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;3.301</td><td align="center" valign="top" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" rowspan="1" colspan="1">3.024, 1.390&#x02009;~&#x02009;6.578</td><td align="center" valign="middle" rowspan="1" colspan="1">0.005</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CBC</td><td align="center" valign="top" rowspan="1" colspan="1">1.57(1.37,2.14)</td><td align="center" valign="top" rowspan="1" colspan="1">1.39(1.17,1.86)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.856</td><td align="center" valign="top" rowspan="1" colspan="1">0.012</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p><sup>a</sup><italic>T</italic> value; <sup>b</sup><italic>&#x003c7;</italic><sup>2</sup> value; <sup>c</sup><italic>Z</italic> value; HPS, Hyperperfusion syndrome.</p></table-wrap-foot></table-wrap></sec><sec id="sec16"><title>Risk factors for HPS syndrome</title><p>In the HPS group (14 patients), the AUC<sub>TTP</sub> of the DMCA was significantly larger (T&#x02009;=&#x02009;&#x02212;3.301, <italic>p</italic>&#x02009;=&#x02009;0.004) and the TTP of the CBC was shorter (T&#x02009;=&#x02009;&#x02212;2.929, <italic>p</italic>&#x02009;=&#x02009;0.005) compared to that in the non-HPS group. Multivariate logistic regression analysis indicated that the larger AUC<sub>TTP</sub> of the DMCA (OR&#x02009;=&#x02009;3.024, 95% CI: 1.390&#x02009;~&#x02009;6.578, <italic>p</italic>&#x02009;=&#x02009;0.0050) was an independent risk factor for HPS.</p></sec></sec><sec sec-type="discussion" id="sec17"><title>Discussion</title><p>Chronic internal carotid artery occlusion is associated with a 5&#x02013;8% annual risk of stroke, even under medical treatment (<xref rid="ref8" ref-type="bibr">8</xref>, <xref rid="ref9" ref-type="bibr">9</xref>). STA-MCA artery bypass, as a low-flow bypass, can reduce the risk of recurrence ipsilateral ischemic stroke, however, would result in HPS-significant focal increase in cerebral blood flow at the site of the anastomosis, which is responsible for postoperative neurological deterioration (<xref rid="ref10" ref-type="bibr">10</xref>). HPS was first reported by Masaaki in 1998 (<xref rid="ref11" ref-type="bibr">11</xref>) and the occurrence rate of HPS could be from 4.4% to even 67.5% (<xref rid="ref12" ref-type="bibr">12&#x02013;16</xref>). In our cohort, the rate was 18.2%, and the HPS-related symptoms included aphasia, hemiparesis, dysarthria, seizure (<xref rid="ref17" ref-type="bibr">17&#x02013;21</xref>). A variety of clinical features have been studied as key risk factors associated with HPS, including preoperative hypertension, weak posterior circulation (<xref rid="ref22" ref-type="bibr">22</xref>), the hemodynamic sources of the recipient parasylvian cortical arteries (<xref rid="ref23" ref-type="bibr">23</xref>), and a longer delay time at CTP (<xref rid="ref24" ref-type="bibr">24</xref>). At present, there are still no reliable models to predict the occurrence of HPS in patients with CICAO after bypass surgery.</p><p>ICG fluorescence is a new semiquantitative-visual technique that has been applied for the intraoperative detection of cerebrovascular disease (<xref rid="ref25" ref-type="bibr">25&#x02013;27</xref>). Zhang et al. further optimized the parameters of ICG mapping to include peak cerebral blood volume, regional cerebral blood flow, and TTP using FLOW 800 software. Moreover, they found that the differences in peak cerebral blood volume and regional cerebral blood flow before and after bypass were significantly higher in the symptomatic group (<xref rid="ref28" ref-type="bibr">28</xref>).</p><p>According to hemodynamic Hagen&#x02013;Poiseuille equation (<xref rid="ref29" ref-type="bibr">29</xref>), Hu put forward the basic principle of the &#x02018;flow-controlled&#x02019;, the hemodynamic difference between the donor and recipient arteries should reduce after STA-MCA anastomosis (<xref rid="ref30" ref-type="bibr">30</xref>). Compared with the non-HPS group, the forward volume of the STA in the HPS group was significantly lower, identified using a phase-contrast MRI technique in our previous study (<xref rid="ref20" ref-type="bibr">20</xref>). However, the obvious flaws of phase-contrast MRI technique include excessively long detection times and fuzzy imaging owing to patient movement, which lead to data bias and difficulty in clinical application (<xref rid="ref20" ref-type="bibr">20</xref>). In operative practice, we believe that high blood flow in the STA after bypass is an important cause of HPS and follow a principle of matching selection of donor and recipient vessels (<xref rid="ref31" ref-type="bibr">31</xref>). Using the ICG fluorescence angiography technique, we can directly choose ROIs at the cortical surface, including blood vessels, from the arterial to the capillary and venous stage. Its parameters include TTP and AUC, representing blood flow velocity and blood flow volume, respectively, which are more accurate than the parameters employed in previous hemodynamic research techniques.</p><p>A higher STA blood flow results in abnormally high local cerebral perfusion. It was verified that after anastomosis, the circulatory resistance of distal STA suddenly and significantly decreased, and the blood flow of the receptor passively increased (<xref rid="ref32" ref-type="bibr">32</xref>). If the STA undergoes compensatory thickening after bypass, patients will show higher rates of headache (<xref rid="ref33" ref-type="bibr">33</xref>). In <xref rid="fig1" ref-type="fig">Figures 1A</xref>&#x02013;<xref rid="fig1" ref-type="fig">C</xref>, the blood flow of STA was ejected directly into the MCA-M4 receptor at a high rate of speed, and the fluorescence intensity of the STA was the highest at all cortex blood vessels according to automatic analysis of FLOW-800, which showed that the higher blood flow of the STA appeared in the ultra-early period after anastomosis. According to the Mann&#x02013;Whitney U-pair analysis, the AUI<sub>TTP</sub> value of the DMCA was significantly larger in the HPS group, confirming that the flow of the DMCA passively increased after bypass.</p><p>In contrast, some patients with weaker vascular networks could not withstand changes in blood flow. In this study, the TTP of the CBC was shorter in the HPS group, indicating that the patients with HPS had a weaker buffering function of the CBC than those without. When foreign and reversed STA blood flow is ejected, it may cause further damage to the entire cerebrovascular network, particularly in patients with weaker CBC function. The results of this study proved again that cerebral perfusion around the anastomosis increased after surgery in the HPS group and that if the cerebral perfusion was excessive, postoperative complications could occur (<xref rid="ref34" ref-type="bibr">34</xref>).</p><p>If high HPS risks are found during surgery, several measures will be adopted in our center. Blood pressure should be maintained at &#x0003c;125/85&#x02009;mmHg by continuous monitoring every 1&#x02009;h (<xref rid="ref35" ref-type="bibr">35</xref>). Nimodipine is used routinely in postoperative patients and nicardipine is proposed by intravenous maintenance for those with high blood pressure. Edaravone as a free radical scavenger (<xref rid="ref36" ref-type="bibr">36</xref>) and Dl-3-n-Butylphthalide approved by Food and Drug Administration of China for treating ischemic stroke (<xref rid="ref37" ref-type="bibr">37</xref>), are considered to be effective in reducing HPS by our experience. However, the measures for treating HPS also should be assessed by randomized controlled trials for the efficacy and safety.</p><sec id="sec18"><title>Limitation</title><p>This study was a single-center, small sample retrospective study, underlying HPS risk factors such as age, comorbidities, and stroke severity were not differentiated, intraoperative anesthesia status was also not considered. Some HPS patients may be missed, because not all patients were tested by postoperative CTP. In the future, prospective randomized controlled trials in multicenter are needed to further confirm its reliability.</p></sec></sec><sec sec-type="conclusions" id="sec19"><title>Conclusion</title><p>Intraoperative fluorescein videoangiography FLOW 800 could predict the risk of HPS in patients with CICAO after bypass surgery. A large AUC of DMCA is an important risk factor for HPS.</p></sec><sec sec-type="data-availability" id="sec20"><title>Data availability statement</title><p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></sec><sec sec-type="ethics-statement" id="sec21"><title>Ethics statement</title><p>The studies involving humans were approved by Ethics Committee of Huadong Hospital, Fudan University. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p></sec><sec sec-type="author-contributions" id="sec22"><title>Author contributions</title><p>JD: Writing &#x02013; original draft. JS: Data curation, Writing &#x02013; review &#x00026; editing. JL: Data curation, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. FZ: Funding acquisition, Writing &#x02013; review &#x00026; editing. RM: Supervision, Validation, Writing &#x02013; original draft. YX: Formal Analysis, Methodology, Resources, Writing &#x02013; review &#x00026; editing. YD: Conceptualization, Supervision, Writing &#x02013; original draft.</p></sec></body><back><sec sec-type="COI-statement" id="sec24"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="sec100"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lall</surname><given-names>A</given-names></name><name><surname>Yavagal</surname><given-names>DR</given-names></name><name><surname>Bornak</surname><given-names>A</given-names></name></person-group>. <article-title>Chronic total occlusion and spontaneous recanalization of the internal carotid artery: natural history and management strategy</article-title>. <source>Vascular</source>. (<year>2021</year>) <volume>29</volume>:<fpage>733</fpage>&#x02013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1177/1708538120978043</pub-id>, PMID: <pub-id pub-id-type="pmid">33297876</pub-id>
</mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wouters</surname><given-names>A</given-names></name><name><surname>Smets</surname><given-names>I</given-names></name><name><surname>Van den Noortgate</surname><given-names>W</given-names></name><name><surname>Steinberg</surname><given-names>GK</given-names></name><name><surname>Lemmens</surname><given-names>R</given-names></name></person-group>. <article-title>Cerebrovascular events after surgery versus conservative therapy for moyamoya disease: a meta-analysis</article-title>. <source>Acta Neurol Belg</source>. (<year>2019</year>) <volume>119</volume>:<fpage>305</fpage>&#x02013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s13760-019-01165-9</pub-id>, PMID: <pub-id pub-id-type="pmid">31215004</pub-id>
</mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>YH</given-names></name><name><surname>Liu</surname><given-names>HM</given-names></name></person-group>. <article-title>Update on cerebral hyperperfusion syndrome</article-title>. <source>J Neurointerv Surg</source>. (<year>2020</year>) <volume>12</volume>:<fpage>788</fpage>&#x02013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1136/neurintsurg-2019-015621</pub-id><pub-id pub-id-type="pmid">32414892</pub-id>
</mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turpin</surname><given-names>J</given-names></name><name><surname>Lynch</surname><given-names>DG</given-names></name><name><surname>White</surname><given-names>T</given-names></name><name><surname>Shah</surname><given-names>KA</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Katz</surname><given-names>JM</given-names></name><etal/></person-group>. <article-title>Hyperperfusion syndrome after superficial temporal artery-middle cerebral artery bypass for non-moyamoya steno-occlusive disease</article-title>. <source>J Stroke Cerebrovasc Dis</source>. (<year>2023</year>) <volume>32</volume>:<fpage>107222</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2023.107222</pub-id>, PMID: <pub-id pub-id-type="pmid">37384979</pub-id>
</mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>M</given-names></name><name><surname>Saga</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>H</given-names></name><name><surname>Noro</surname><given-names>S</given-names></name><name><surname>Wada</surname><given-names>H</given-names></name><name><surname>Kamada</surname><given-names>K</given-names></name></person-group>. <article-title>Quantitative blood flow assessment by multiparameter analysis of indocyanine green video angiography</article-title>. <source>World Neurosurg</source>. (<year>2018</year>) <volume>116</volume>:<fpage>e187</fpage>&#x02013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.wneu.2018.04.148</pub-id>, PMID: <pub-id pub-id-type="pmid">29729470</pub-id>
</mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>J</given-names></name><name><surname>Takaku</surname><given-names>A</given-names></name></person-group>. <article-title>Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain</article-title>. <source>Arch Neurol</source>. (<year>1969</year>) <volume>20</volume>:<fpage>288</fpage>&#x02013;<lpage>99</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archneur.1969.00480090076012</pub-id><pub-id pub-id-type="pmid">5775283</pub-id>
</mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delgado</surname><given-names>MG</given-names></name><name><surname>Bogousslavsky</surname><given-names>J</given-names></name></person-group>. <article-title>Cerebral Hyperperfusion syndrome and related conditions</article-title>. <source>Eur Neurol</source>. (<year>2020</year>) <volume>83</volume>:<fpage>453</fpage>&#x02013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000511307</pub-id>, PMID: <pub-id pub-id-type="pmid">33070131</pub-id>
</mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persoon</surname><given-names>S</given-names></name><name><surname>Luitse</surname><given-names>MJ</given-names></name><name><surname>de Borst</surname><given-names>GJ</given-names></name><name><surname>van der Zwan</surname><given-names>A</given-names></name><name><surname>Algra</surname><given-names>A</given-names></name><name><surname>Kappelle</surname><given-names>LJ</given-names></name><etal/></person-group>. <article-title>Symptomatic internal carotid artery occlusion: a long-term follow-up study</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. (<year>2011</year>) <volume>82</volume>:<fpage>521</fpage>&#x02013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1136/jnnp.2010.208330</pub-id><pub-id pub-id-type="pmid">20884678</pub-id>
</mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Tong</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Kuai</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>The carotid and middle cerebral artery occlusion surgery study (CMOSS): a study protocol for a randomised controlled trial</article-title>. <source>Trials</source>. (<year>2016</year>) <volume>17</volume>:<fpage>544</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13063-016-1600-1</pub-id>, PMID: <pub-id pub-id-type="pmid">27852286</pub-id>
</mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thanapal</surname><given-names>S</given-names></name><name><surname>Duvuru</surname><given-names>S</given-names></name><name><surname>Sae-Ngow</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Takizawa</surname><given-names>K</given-names></name></person-group>. <article-title>Direct Cerebral Revascularization: Extracranial-intracranial Bypass</article-title>. <source>Asian J Neurosurg</source>. (<year>2018</year>) <volume>13</volume>:<fpage>9</fpage>&#x02013;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.4103/ajns.AJNS_76_17</pub-id>, PMID: <pub-id pub-id-type="pmid">29492114</pub-id>
</mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uno</surname><given-names>M</given-names></name><name><surname>Nakajima</surname><given-names>N</given-names></name><name><surname>Nishi</surname><given-names>K</given-names></name><name><surname>Shinno</surname><given-names>K</given-names></name><name><surname>Nagahiro</surname><given-names>S</given-names></name></person-group>. <article-title>Hyperperfusion syndrome after extracranial-intracranial bypass in a patient with moyamoya disease--case report</article-title>. <source>Neurol Med Chir (Tokyo)</source>. (<year>1998</year>) <volume>38</volume>:<fpage>420</fpage>&#x02013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.2176/nmc.38.420</pub-id><pub-id pub-id-type="pmid">9745249</pub-id>
</mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimura</surname><given-names>M</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Mugikura</surname><given-names>S</given-names></name><name><surname>Saito</surname><given-names>A</given-names></name><name><surname>Tominaga</surname><given-names>T</given-names></name></person-group>. <article-title>Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-(123)Iiodoamphetamine single-photon emission computed tomography</article-title>. <source>Neurosurgery</source>. (<year>2011</year>) <volume>68</volume>:<fpage>957</fpage>&#x02013;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.1227/NEU.0b013e318208f1da</pub-id><pub-id pub-id-type="pmid">21221039</pub-id>
</mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease</article-title>. <source>J Neurosurg</source>. (<year>2018</year>) <volume>1</volume>:<fpage>1</fpage>&#x02013;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.3171/2017.10.JNS171749</pub-id></mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimura</surname><given-names>M</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Saito</surname><given-names>A</given-names></name><name><surname>Mugikura</surname><given-names>S</given-names></name><name><surname>Tominaga</surname><given-names>T</given-names></name></person-group>. <article-title>Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease</article-title>. <source>Cerebrovasc Dis</source>. (<year>2012</year>) <volume>33</volume>:<fpage>436</fpage>&#x02013;<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000336765</pub-id>, PMID: <pub-id pub-id-type="pmid">22456617</pub-id>
</mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanagihara</surname><given-names>W</given-names></name><name><surname>Chida</surname><given-names>K</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Kubo</surname><given-names>Y</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Terasaki</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Impact of cerebral blood flow changes due to arterial bypass surgery on cognitive function in adult patients with symptomatic ischemic moyamoya disease</article-title>. <source>J Neurosurg</source>. (<year>2018</year>) <volume>131</volume>:<fpage>1716</fpage>&#x02013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.3171/2018.7.JNS18149</pub-id>, PMID: <pub-id pub-id-type="pmid">30554180</pub-id>
</mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study</article-title>. <source>J Neurosurg</source>. (<year>2018</year>) <volume>128</volume>:<fpage>1327</fpage>&#x02013;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.3171/2016.12.JNS162626</pub-id>, PMID: <pub-id pub-id-type="pmid">28686113</pub-id>
</mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Oh</surname><given-names>CW</given-names></name><name><surname>Kwon</surname><given-names>OK</given-names></name><name><surname>Park</surname><given-names>SQ</given-names></name><name><surname>Kim</surname><given-names>SE</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name></person-group>. <article-title>Transient hyperperfusion after superficial temporal artery/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration</article-title>. <source>Cerebrovasc Dis</source>. (<year>2008</year>) <volume>25</volume>:<fpage>580</fpage>&#x02013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000132205</pub-id>, PMID: <pub-id pub-id-type="pmid">18483458</pub-id>
</mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimura</surname><given-names>M</given-names></name><name><surname>Kaneta</surname><given-names>T</given-names></name><name><surname>Mugikura</surname><given-names>S</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Tominaga</surname><given-names>T</given-names></name></person-group>. <article-title>Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease</article-title>. <source>Surg Neurol</source>. (<year>2007</year>) <volume>67</volume>:<fpage>273</fpage>&#x02013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.surneu.2006.07.017</pub-id>, PMID: <pub-id pub-id-type="pmid">17320638</pub-id>
</mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohue</surname><given-names>S</given-names></name><name><surname>Kumon</surname><given-names>Y</given-names></name><name><surname>Kohno</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Iwata</surname><given-names>S</given-names></name><name><surname>Ohnishi</surname><given-names>T</given-names></name></person-group>. <article-title>Postoperative temporary neurological deficits in adults with moyamoya disease</article-title>. <source>Surg Neurol</source>. (<year>2008</year>) <volume>69</volume>:<fpage>281</fpage>&#x02013;<fpage>6</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.surneu.2007.01.047</pub-id> PMID: <pub-id pub-id-type="pmid">17996267</pub-id>
</mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>G</given-names></name><name><surname>Ji</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Phase-contrast magnetic resonance imaging analysis of cerebral Hyperperfusion syndrome after surgery in adult patients with Moyamoya disease</article-title>. <source>World Neurosurg</source>. (<year>2019</year>) <volume>129</volume>:<fpage>e48</fpage>&#x02013;<lpage>55</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.wneu.2019.04.191</pub-id>, PMID: <pub-id pub-id-type="pmid">31051310</pub-id>
</mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group>. <article-title>Cerebral Hyperperfusion syndrome after revascularization surgery in patients with Moyamoya disease: systematic review and Meta-analysis</article-title>. <source>World Neurosurg</source>. (<year>2020</year>) <volume>135</volume>:<fpage>357</fpage>&#x02013;<lpage>366.e4</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.wneu.2019.11.065</pub-id>, PMID: <pub-id pub-id-type="pmid">31759149</pub-id>
</mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Postoperative hemorrhage during the acute phase after direct or combined revascularization for moyamoya disease: risk factors, prognosis, and literature review</article-title>. <source>J Neurosurg</source>. (<year>2019</year>) <volume>18</volume>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.3171/2019.7.JNS19885</pub-id></mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Fujimura</surname><given-names>M</given-names></name><name><surname>Lau</surname><given-names>TY</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Hemodynamic analysis of the recipient parasylvian cortical arteries for predicting postoperative hyperperfusion during STA-MCA bypass in adult patients with moyamoya disease</article-title>. <source>J Neurosurg</source>. (<year>2019</year>) <volume>134</volume>:<fpage>17</fpage>&#x02013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.3171/2019.10.JNS191207</pub-id>, PMID: <pub-id pub-id-type="pmid">31881540</pub-id>
</mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>F</given-names></name><name><surname>Han</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name></person-group>. <article-title>Assessment of transient cerebral hemodynamic disturbance via whole-brain computed tomography perfusion after extracranial-intracranial bypass in ischemic Moyamoya disease</article-title>. <source>World Neurosurg</source>. (<year>2021</year>) <volume>146</volume>:<fpage>e112</fpage>&#x02013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.wneu.2020.10.046</pub-id>, PMID: <pub-id pub-id-type="pmid">33069937</pub-id>
</mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raabe</surname><given-names>A</given-names></name><name><surname>Beck</surname><given-names>J</given-names></name><name><surname>Gerlach</surname><given-names>R</given-names></name><name><surname>Zimmermann</surname><given-names>M</given-names></name><name><surname>Seifert</surname><given-names>V</given-names></name></person-group>. <article-title>Near-infrared indocyanine green video angiography: a new method for intraoperative assessment of vascular flow</article-title>. <source>Neurosurgery</source>. (<year>2003</year>) <volume>52</volume>:<fpage>132</fpage>&#x02013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1097/00006123-200301000-00017</pub-id> PMID: <pub-id pub-id-type="pmid">12493110</pub-id>
</mixed-citation></ref><ref id="ref26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takagi</surname><given-names>Y</given-names></name><name><surname>Kikuta</surname><given-names>K</given-names></name><name><surname>Nozaki</surname><given-names>K</given-names></name><name><surname>Sawamura</surname><given-names>K</given-names></name><name><surname>Hashimoto</surname><given-names>N</given-names></name></person-group>. <article-title>Detection of a residual nidus by surgical microscope-integrated intraoperative near-infrared indocyanine green videoangiography in a child with a cerebral arteriovenous malformation</article-title>. <source>J Neurosurg</source>. (<year>2007</year>) <volume>107</volume>:<fpage>416</fpage>&#x02013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.3171/PED-07/11/416</pub-id>, PMID: <pub-id pub-id-type="pmid">18459907</pub-id>
</mixed-citation></ref><ref id="ref27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eun</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Park</surname><given-names>JC</given-names></name><name><surname>Ahn</surname><given-names>JS</given-names></name><name><surname>Kwun</surname><given-names>BD</given-names></name><name><surname>Park</surname><given-names>W</given-names></name></person-group>. <article-title>Efficacy of intraoperative neuromonitoring (IONM) and intraoperative indocyanine green videoangiography (ICG-VA) during unruptured anterior choroidal artery aneurysm clipping surgery</article-title>. <source>J Cerebrovasc Endovasc Neurosurg</source>. (<year>2023</year>) <volume>25</volume>:<fpage>150</fpage>&#x02013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.7461/jcen.2023.E2022.10.008</pub-id>, PMID: <pub-id pub-id-type="pmid">36693397</pub-id>
</mixed-citation></ref><ref id="ref28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Ni</surname><given-names>W</given-names></name><name><surname>Feng</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Lei</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Evaluation of hemodynamic change by indocyanine green-FLOW 800 videoangiography mapping: prediction of hyperperfusion syndrome in patients with moyamoya disease</article-title>. <source>Oxidative Med Cell Longev</source>. (<year>2020</year>) <volume>2020</volume>:<fpage>8561609</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2020/8561609</pub-id></mixed-citation></ref><ref id="ref29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>AP</given-names></name><name><surname>Ray</surname><given-names>CJ</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Coney</surname><given-names>AM</given-names></name></person-group>. <article-title>A student practical to conceptualize the importance of Poiseuille's law and flow control in the cardiovascular system</article-title>. <source>Adv Physiol Educ</source>. (<year>2020</year>) <volume>44</volume>:<fpage>436</fpage>&#x02013;<lpage>43</lpage>. doi: <pub-id pub-id-type="doi">10.1152/advan.00004.2019</pub-id>, PMID: <pub-id pub-id-type="pmid">32697152</pub-id>
</mixed-citation></ref><ref id="ref30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group>. <article-title>Designing a flow-controlled STA-MCA anastomosis based on the Hagen-Poiseuille law for preventing postoperative hyperperfusion in adult moyamoya disease</article-title>. <source>Ther Adv Chronic Dis</source>. (<year>2023</year>) <volume>14</volume>:<fpage>20406223231181492</fpage>. doi: <pub-id pub-id-type="doi">10.1177/20406223231181492</pub-id>, PMID: <pub-id pub-id-type="pmid">37465163</pub-id>
</mixed-citation></ref><ref id="ref31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>X</given-names></name><name><surname>Su</surname><given-names>K</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group>. <article-title>Matching selection of donor-recipient vessels in revascularization surgery effectively reduce the incidence of postoperative Hyperperfusion syndrome in adult Moyamoya disease: a retrospective comparison study</article-title>. <source>Cerebrovasc Dis</source>. (<year>2020</year>) <volume>49</volume>:<fpage>361</fpage>&#x02013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000509138</pub-id>, PMID: <pub-id pub-id-type="pmid">32674110</pub-id>
</mixed-citation></ref><ref id="ref32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>MX</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name></person-group>. <article-title>Effect of adventitial dissection of superficial temporal artery on the outcome of superficial temporal artery-middle cerebral artery bypass in Moyamoya disease</article-title>. <source>Aging Dis</source>. (<year>2017</year>) <volume>8</volume>:<fpage>384</fpage>&#x02013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.14336/AD.2016.1115</pub-id>, PMID: <pub-id pub-id-type="pmid">28840053</pub-id>
</mixed-citation></ref><ref id="ref33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katano</surname><given-names>H</given-names></name><name><surname>Nishikawa</surname><given-names>Y</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Shibata</surname><given-names>T</given-names></name><name><surname>Miyachi</surname><given-names>S</given-names></name><name><surname>Mase</surname><given-names>M</given-names></name></person-group>. <article-title>Association of Superficial Temporal Artery Dilatation with headache after revascularization in adult Moyamoya disease</article-title>. <source>World Neurosurg</source>. (<year>2019</year>) <volume>129</volume>:<fpage>e594</fpage>&#x02013;<lpage>606</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.wneu.2019.05.228</pub-id>, PMID: <pub-id pub-id-type="pmid">31158538</pub-id>
</mixed-citation></ref><ref id="ref34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noguchi</surname><given-names>T</given-names></name><name><surname>Kawashima</surname><given-names>M</given-names></name><name><surname>Nishihara</surname><given-names>M</given-names></name><name><surname>Egashira</surname><given-names>Y</given-names></name><name><surname>Azama</surname><given-names>S</given-names></name><name><surname>Irie</surname><given-names>H</given-names></name></person-group>. <article-title>Noninvasive method for mapping CVR in moyamoya disease using ASL-MRI</article-title>. <source>Eur J Radiol</source>. (<year>2015</year>) <volume>84</volume>:<fpage>1137</fpage>&#x02013;<lpage>43</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejrad.2015.03.011</pub-id>, PMID: <pub-id pub-id-type="pmid">25816991</pub-id>
</mixed-citation></ref><ref id="ref35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouri</surname><given-names>S</given-names></name><name><surname>Thapar</surname><given-names>A</given-names></name><name><surname>Shalhoub</surname><given-names>J</given-names></name><name><surname>Jayasooriya</surname><given-names>G</given-names></name><name><surname>Fernando</surname><given-names>A</given-names></name><name><surname>Franklin</surname><given-names>IJ</given-names></name><etal/></person-group>. <article-title>Hypertension and the post-carotid endarterectomy cerebral hyperperfusion syndrome</article-title>. <source>Eur J Vasc Endovasc Surg</source>. (<year>2011</year>) <volume>41</volume>:<fpage>229</fpage>&#x02013;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejvs.2010.10.016</pub-id>, PMID: <pub-id pub-id-type="pmid">21131217</pub-id>
</mixed-citation></ref><ref id="ref36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogasawara</surname><given-names>K</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Endo</surname><given-names>H</given-names></name><name><surname>Fukuda</surname><given-names>T</given-names></name><name><surname>Ogawa</surname><given-names>A</given-names></name></person-group>. <article-title>Pretreatment with the free radical scavenger edaravone prevents cerebral hyperperfusion after carotid endarterectomy</article-title>. <source>Neurosurgery</source>. (<year>2004</year>) <volume>55</volume>:<fpage>1060</fpage>&#x02013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1227/01.NEU.0000140838.27450.63</pub-id>, PMID: <pub-id pub-id-type="pmid">15509312</pub-id>
</mixed-citation></ref><ref id="ref37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>F</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Xing</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Dl-3-n-butylphthalide (NBP): a promising therapeutic agent for ischemic stroke</article-title>. <source>CNS Neurol Disord Drug Targets</source>. (<year>2018</year>) <volume>17</volume>:<fpage>338</fpage>&#x02013;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1871527317666180612125843</pub-id>, PMID: <pub-id pub-id-type="pmid">29895257</pub-id>
</mixed-citation></ref></ref-list></back></article>
